BOTBOT was in a rather different situation where the FDA indicated that they would grant approval if some minor changes were made, so approval was pretty much already priced in. MSB seems to have a higher degree of uncertainty (personally I would like to say I am certain of approval but that wouldn't be true). Maybe 80 - 90%? So I would expect the sp to double on approval if not a bit more but hopes of a lot more seem a bit unrealistic. Of course, I hope I am wrong!
BOT BOT was in a rather different situation where the FDA...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |